The clinical safety of H1-receptor antagonists. An EAACI position paper.
DIMI Department of Internal Medicine, Genoa University, Italy.
G
G
Passalacqua
J
J
Bousquet
C
C
Bachert
M K
MK
Church
C
C
Bindsley-Jensen
L
L
Nagy
P
P
Szemere
R J
RJ
Davies
S R
SR
Durham
F
F
Horak
K
K
Kontou-Fili
H J
HJ
Malling
P
P
van Cauwenberge
G W
GW
Canonica
D016907:Adverse Drug Reaction Reporting Systems; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004353:Drug Evaluation, Preclinical; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000145:classification; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced; D018579:Patient Selection; D012449:Safety; D012894:Sleep Stages / Q000187:drug effects
D006634:Histamine H1 Antagonists